Beyond Biotech - the podcast from Labiotech cover image

Beyond Biotech - the podcast from Labiotech

The biotech investment landscape in 2024

Apr 19, 2024
The podcast delves into the biotech investment landscape in 2024 with a focus on financing for innovative companies. Topics include evaluating biotech companies, raising funds, undervalued sectors, M&As, IPOs, major trends in biotech, impact of US elections, royalties market, regional differences, and getting good biotech deals today.
28:32

Podcast summary created with Snipd AI

Quick takeaways

  • RTW Investments focuses on next-gen gene therapies and rare diseases in biotech investments.
  • Creative financing strategies are crucial for biotech companies to navigate capital fluctuations.

Deep dives

RTW Investments and their Full Life Cycle Investment Approach

RTW Investments, a $7 billion global multi-strategy investment firm, focuses on supporting innovative biotech and biopharma companies across their entire life cycle. They specialize in next-generation gene and RNA therapies, rare diseases, oncology, cardiovascular, and neurological disorders. RTW started in public-listed companies, moved to late-stage pre-IPO rounds, and even created Rocket Pharma from academic assets to drive clinical trials forward.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode